13 PCORI's Merit Review Process€¦ · Recruiting Reviewers • Targeted&recruitmentof&reviewers&...
Transcript of 13 PCORI's Merit Review Process€¦ · Recruiting Reviewers • Targeted&recruitmentof&reviewers&...
PCORI’s Merit Review Process
Mari Kimura, PhD Merit Review Officer February 20, 2015
Mari Kimura, PhD Merit Review Officer
Welcome!
2
Session Objectives
• Introduce PCORI Merit Reviewers – Who are the reviewers?
• Outline the Merit Review process – What happens to applicaCons aDer submission? – How do the reviewers evaluate applicaCons?
3
Goal of PCORI Merit Review
4
To identify applications that have the strongest potential to improve patient outcomes
Building an Inclusive Merit Review
• Panels include scienCsts, paCents, and other stakeholders to bring diverse perspecCves to the review process.
• Each applicaCon is assigned to 2 scienCsts, 1 paCent, and 1 other stakeholder.
• Chair facilitates discussion and promotes a culture of mutual respect and understanding among reviewer types
5
Patients Other Stakeholders
Scientists
Reviewer Eligibility
• ScienCsts – Advanced degree in health or
research-‐related field – Relevant peer-‐reviewed
publicaCons – AcCve research program in a
relevant field of study • Chairs
– NaConal reputaCon in research area
– Demonstrated leadership experience
6
Reviewer Eligibility
• Stakeholders – Contribute a unique healthcare
system perspecCve • PaCents
– PaCent advocates – Caregivers
• Excluded – Board of Governors – SelecCon CommiWee members – Applicants
7
Where Do Our Reviewers Come From?
8
Merit Reviewers by Role
9
N=3897
Stakeholder 32%
Pa<ent 12%
Scien<fic 56%
Diverse Stakeholder Roles in Reviewer Pool
10
Clinician 33%
Hospital or Health System
11% Industry
5% Payer
2%
Policy Maker 4%
Researcher 35%
Training Institution
5%
Unsure 5%
11
Responsiveness Review
12
• LeWers of intent (LOIs) are reviewed (by PCORI or external reviewers) based on criteria detailed in each PCORI funding announcement (PFA).
• AddiConal screening for – ComparaCve effecCveness research – Exclusion of cost-‐effecCveness analysis – ProgrammaCc concerns
• Only responsive LOIs will be invited to submit a full applicaCon.
Comparative Effectiveness Research
Exclusion of Cost-Effectiveness Analysis
Programmatic Fit
Recruiting Reviewers
• Targeted recruitment of reviewers and panel Chair following based on topic areas of accepted LOIs
• Reviewers invited based on experCse/perspecCve
13
14
Application Assignments
15
ApplicaCon assignments based on
ExperCse ConsideraCon of COI
About 6 applicaCons per reviewer
All panel reviewers have training
Web Based Training
Program-‐led Webinars
Approximately 4 weeks to review assigned applicaCons
PaCent and Other Stakeholder reviewers receive addiConal training
Mentor program supplements
training
AddiConal training aids such as
Methodology 101
Mentor Program
16
Complete wriWen criCques
that are informaCve for applicants and program staff
ParCcipate effecCvely at the panel meeCng
Enjoy parCcipaCng in the PCORI Merit Review process
Provides paCent and
other stakeholder reviewers the support they
need to
17
Critique Review by MROs and Mentors
• All reviewers write a criCque for each of their assigned applicaCons and provide criterion scores and overall scores
• All reviewers will receive feedback on wriWen criCques from Mentors and Merit Review Officers who review criCques as panel members complete them – Clarifies goals of PFA and content of criCques – Helps reviewers express their unique perspecCve in a manner that is acConable by the applicant
– Ensures fair and consistent review
18
Merit Review Criteria
19
Criterion #1: Impact of the condiCon on the health of individuals and populaCon
Criterion #2: PotenCal for the study to improve healthcare and outcomes
Criterion #3: Technical merit
Criterion #4: PaCent-‐centeredness
Criterion #5: PaCent and other stakeholder engagement
Pa<ent and Other
Stakeholder Reviewers
Scien<st Reviewers
We Require Patient-Centeredness and Patient and Other Stakeholder Engagement
Patient and Other Stakeholder Engagement
• PaCents are partners in research, not just “subjects”
• AcCve and meaningful engagement between scienCsts, paCents, and other stakeholders
• Community, paCent, and caregiver involvement already in existence or a well-‐thought out plan throughout the project
Patient-Centeredness • Does the project aim to answer
quesCons or examine outcomes that maWer to paCents within the context of paCent preferences?
• Research quesCons and outcomes should reflect what is important to paCents and caregivers
20
Additional Considerations
21
Adherence to Methodology Standards
Human Subjects
ProtecCons
Scoring Range
22
Range Score Descriptor Characteris<cs
High
1 ExcepConal ExcepConally strong with essenCally no weaknesses
2 Outstanding Extremely strong with negligible weaknesses
3 Excellent Very strong with only some minor weaknesses
Medium
4 Very Good Strong but with numerous minor weaknesses
5 Good Strong but with at least one moderate weakness
6 SaCsfactory Some strengths but also some moderate weakness
Low
7 Fair Some strengths but with at least one major weakness
8 Marginal A few strengths and a few major weaknesses
9 Poor Very few strengths and numerous major weaknesses
A score of 1 indicates an excepConally strong applicaCon.
A score of 9 indicates an applicaCon with serious and substanCve weaknesses.
23
Setting the Discussion Line
24
PCORI program staff consider numerical scores
ApplicaCons of parCcular interest to programs can be included in discussion
ProporCon of applicaCons discussed depends on scores and varies among PFAs
25
Merit Review In-Person Meeting
26
Chair Introduces Application
Reviewer 1: Scientist 1
Reviewer 2: Patient
Reviewer 3: Stakeholder
Reviewer 4: Scientist 2
Descrip<on
Chair briefly introduces applicaCon
4 lead reviewers present score and highlights of their criCques General panel discussion facilitated by Chair Chair summarizes panel discussion of applicaCon All panel reviewers score applicaCon
Discussion Components
• The five Merit Review criteria • ProgrammaCc goals as defined in the PFA
How each applica<on addresses
• Methodological rigor in a project leads to trustworthy, paCent-‐centered informaCon
Emphasis on importance of rigorous science
• Responsiveness to comments from original review are considered but not a guarantee of funding
Resubmissions reviewed as standalone applica<on
27
Strategies for Preparing a Successful Funding Application
28
Your applicaCon should tell the story of why the proposed study is important to all reviewers
Don’t assume reviewers know something about your project that you don’t address
Be clear on what is to be gained if your study is funded
28
NOTE All of the guidance provided to reviewers is available at PCORI.org under Reviewer Resources.
29
30
31
Summary Statements
• All applicants receive a summary statement at the end of the review cycle.
• Preliminary reviewer criCques
• Notes from applicaCon discussion
• Final panel average overall score
If the applica<on is discussed, summary statement includes:
• Preliminary reviewer criCques
If the applica<on is not discussed, summary statement includes:
32
Become a Reviewer
• PCORI review panels include scienCsts, paCents, and other stakeholders to bring diverse perspecCves to the review process.
• We conCnue to welcome applicaCons to become a reviewer in all categories.
33
How to Apply to be a PCORI Reviewer
Visit: www.pcori.org/content/become-reviewer
• Qualifications
• Reviewer Expectations
• Compensation
• Training Materials
34
Questions?
Thank You! Mari Kimura, PhD Merit Review Officer